About x-cardiac

x-cardiac has developed an AI-based platform that predicts life-threatening complications, such as postoperative bleeding and renal injury, immediately upon patient admission to the ICU. This clinically validated system integrates with hospital IT infrastructure to enhance decision-making and facilitate timely interventions, ultimately improving patient outcomes after heart surgery.

```xml <problem> Patients in cardiac intensive care units are at risk of life-threatening complications such as postoperative bleeding and renal injury. Early detection of these complications is critical for timely intervention and improved patient outcomes, but current methods often lack the speed and precision needed for optimal care. </problem> <solution> x-cardiac offers an AI-powered clinical decision support platform designed to predict postoperative complications immediately upon a patient's admission to the ICU. The MDR-certified platform seamlessly integrates into existing hospital IT systems, adding a layer of clinically meaningful information to the hospital database system. By analyzing real-time data, x-cardiac's algorithms can detect potential complications like postoperative bleeding (using the x-c-bleeding™ plug-in) and renal injury (using the x-c-renal-injury™ plug-in) allowing for rapid intervention. The massively scalable approach is designed for various indications and different ICUs. </solution> <features> - AI-based prediction of postoperative bleeding and renal injury - Seamless integration with hospital IT systems - Real-time analysis of patient data upon ICU admission - MDR-certified for safety and performance - x-c-bleeding™ plug-in targeting postoperative bleeding prediction - x-c-renal-injury™ plug-in targeting early detection of renal injury - Local validation of algorithms for each customer with optional fine-tuning </features> <target_audience> The primary target audience includes medical professionals in cardiac intensive care units, such as physicians and nurses, as well as hospital systems seeking to improve patient safety and outcomes after heart surgery. </target_audience> ```

What does x-cardiac do?

Where is x-cardiac located?

x-cardiac is based in Berlin, Germany.

When was x-cardiac founded?

x-cardiac was founded in 2021.

Location

Berlin, Germany

Founded

2021

Employees

10 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

x-cardiac

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

xcardiac.com 500+

Crunchbase

Founded 2021 – Berlin, Germany

Funding

No funding information available.

Team (10+)

No team information available.

Company Description

Problem

Patients in cardiac intensive care units are at risk of life-threatening complications such as postoperative bleeding and renal injury. Early detection of these complications is critical for timely intervention and improved patient outcomes, but current methods often lack the speed and precision needed for optimal care.

Solution

x-cardiac offers an AI-powered clinical decision support platform designed to predict postoperative complications immediately upon a patient's admission to the ICU. The MDR-certified platform seamlessly integrates into existing hospital IT systems, adding a layer of clinically meaningful information to the hospital database system. By analyzing real-time data, x-cardiac's algorithms can detect potential complications like postoperative bleeding (using the x-c-bleeding™ plug-in) and renal injury (using the x-c-renal-injury™ plug-in) allowing for rapid intervention. The massively scalable approach is designed for various indications and different ICUs.

Features

AI-based prediction of postoperative bleeding and renal injury

Seamless integration with hospital IT systems

Real-time analysis of patient data upon ICU admission

MDR-certified for safety and performance

x-c-bleeding™ plug-in targeting postoperative bleeding prediction

x-c-renal-injury™ plug-in targeting early detection of renal injury

Local validation of algorithms for each customer with optional fine-tuning

Target Audience

The primary target audience includes medical professionals in cardiac intensive care units, such as physicians and nurses, as well as hospital systems seeking to improve patient safety and outcomes after heart surgery.